Clinical Trial Update: Study of CM310 in Subjects With Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating CM310 for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED